Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats

References

• Al Maruf A, O’Brien P. 2014. Flutamide-induced cytotoxicity and oxidative stress in an in vitro rat hepatocyte system. Oxid Med Cell Longev. 2014:Article ID 398285.
   PubMed Web of Science ®Google Scholar
• Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T. 2013. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis. BMC Musculoskelet Disord. 14:229–236.
   PubMed Web of Science ®Google Scholar
• Ann SJ, Chung JH, Park BH, Kim SH, Jang J, Park S, Kang SM, Lee SH. 2015. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1. Atherosclerosis 240:389–397.
   PubMed Web of Science ®Google Scholar
• Banchroft GD, Steven A. 1983. Theory and practice of histological technique. 4th ed. London, UK: Churchill Livingstone Publications.
   Google Scholar
• Bellaver B, Souza DG , Souza DO, Quincozes-Santos A. 2014. Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats. Toxicol in Vitro. 28:479–484.
   PubMed Web of Science ®Google Scholar
• Biesen R, Burmester GR, Hiepe F. 2014. [Rheumatoid factor or antinuclear antibodies as incidental finding]. Internist (Berl). 55:1157–1164.
   PubMed Web of Science ®Google Scholar
• Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W. 1993. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 187:317–329.
   PubMed Web of Science ®Google Scholar
• Brown PD. 1998. Synthetic inhibitors of matrix metalloproteinases. In: Parks WC, Mecham RP, editors. Matrix metalloproteases. San Diego (CA): Academic Press. p. 243–261.
   Google Scholar
• Castillero E, Martín AI, Nieto-Bona MP, Fernández-Galaz C, López-Menduiña M, Villanúa MA, López-Calderón A. 2012. Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting. Endocr Connect. 1:1–12.
   PubMedGoogle Scholar
• Chen X, Lu J, An M, Ma Z, Zong H, Yang J. 2014. Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2. Mol Med Rep. 9:2592–2598.
   PubMed Web of Science ®Google Scholar
• Chen XY, Wang ZC, Li J, Liu XL, Sun YH. 2013. Regulation of synoviocyte activity by resveratrol in rats with adjuvant arthritis. Exp Ther Med. 6:172–176.
   PubMed Web of Science ®Google Scholar
• Cianciulli A, Dragone T, Calvello R, Porro C, Trotta T, Lofrumento DD, Panaro MA. 2015. IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int Immunopharmacol. 24:369–376.
   PubMed Web of Science ®Google Scholar
• Edupuganti SR, Eder V, Ternant D, Courtehoux M, Tranquart F, Goupille P, Paintaud G, Mulleman D. 2015. F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis: a prospective pilot study. Joint Bone Spine. 82:381–383
   PubMed Web of Science ®Google Scholar
• Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70–77.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11:81–128.
   PubMed Web of Science ®Google Scholar
• Fahmy Wahba MG, Shehata Messiha BA, Abo-Saif AA. 2015. Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats. Eur J Pharmacol. 765:307–315
   PubMed Web of Science ®Google Scholar
• Glehr M, Breisach M, Walzer S, Lohberger B, Fürst F, Friesenbichler J, Rinner B, Avian A, Windhager R, Leithner A. 2013. The influence of resveratrol on the synovial expression of matrix metalloproteinases and receptor activator of NF-kappaB ligand in rheumatoid arthritis fibroblast-like synoviocytes. Z Naturforsch C. 68:336–342.
   PubMed Web of Science ®Google Scholar
• Gramoun A, Crowe LA, Maurizi L, Wirth W, Tobalem F, Grosdemange K, Coullerez G, Eckstein F, Koenders MI, Van den Berg WB, et al. 2014. Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages. Arthritis Res Ther. 16:R131–R146.
   PubMed Web of Science ®Google Scholar
• Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM. 2001. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol. 132:1565–1573.
   PubMed Web of Science ®Google Scholar
• Haleagrahara N, Tudawe D, Chakravarthi S, Kutty Radhakrishnan A. 2013. Amelioration of collagen-induced arthritis in female dark agouti rats by glucosamine treatment. ISRN Pharmacol. 2013: Article ID 562905.
   PubMedGoogle Scholar
• Haro H, Crawford HC, Fingleton B, MacDougall JR, Shinomiya K, Spengler DM, Matrisian LM. 2000. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest. 105:133–141.
   PubMed Web of Science ®Google Scholar
• Hügle B, Hinze C, Lainka E, Fischer N, Haas JP. 2014. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course. Pediatr Rheumatol Online J. 12:28–32.
   PubMed Web of Science ®Google Scholar
• Ingegnoli F, Castelli R, Gualtierotti R. 2013. Rheumatoid factors: clinical applications. Dis Markers. 35:727–734.
   PubMed Web of Science ®Google Scholar
• Iyer SS, Cheng G. 2012. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 32:23–63.
   PubMed Web of Science ®Google Scholar
• Kawashiri SY, Kawakami A, Ueki Y, Imazato T, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Nakamura H, Origuchi T, et al. 2010. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab. Joint Bone Spine. 77:418–420.
   PubMed Web of Science ®Google Scholar
• Khozeimeh F, Savabi O, Esnaashari M. 2014. Evaluation of interleukin-1α, interleukin-10, tumor necrosis factor-α and transforming growth factor-β in the serum of patients with Pemphigus vulgaris. J Contemp Dent Pract. 15:746–749.
   PubMedGoogle Scholar
• Kim S, Kim JH, Lee JH, Kim HS. 2010. Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects. Rheumatology (Oxford). 49:450–457.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kang JS. 2015. Effect of methotrexate on collagen-induced arthritis assessed by micro-computed tomography and histopathological examination in female rats. Biomol Ther (Seoul). 23:195–200.
   PubMed Web of Science ®Google Scholar
• Kizaki K, Yoshizumi Y, Takahashi T, Era S. 2015. Elevated oxidative stress monitored via the albumin-thiol redox state is correlated with matrix metalloproteinase-3 elevation in patients with rheumatoid arthritis. Clin Lab. 61:175–178.
   PubMed Web of Science ®Google Scholar
• Koufany M, Jouzeau JY, Moulin D. 2014. Fenofibrate vs pioglitazone: comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis. Biomed Mater Eng. 24:81–88.
   PubMed Web of Science ®Google Scholar
• Kripa KG, Chamundeeswari D, Thanka J, Uma Maheswara Reddy C. 2010. Effect of hydroalcoholic extract of aerial parts of Leucas aspera (Willd.) link on inflammatory markers in complete Freund’s adjuvant induced arthritic rats. Int J Green Pharm. 4:281–287.
   Google Scholar
• Krysiak R, Gdula-Dymek A, Okopien B. 2013. The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Basic Clin Pharmacol Toxicol. 112:198–202.
   PubMed Web of Science ®Google Scholar
• Lampropoulos CE, Orfanos P, Bournia VK, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG. 2015. Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. Clin Exp Rheumatol. 33:216–224.
   PubMed Web of Science ®Google Scholar
• Lee JW, Bajwa PJ, Carson MJ, Jeske DR, Cong Y, Elson CO, Lytle C, Straus DS. 2007. Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology 133:108–123.
   PubMed Web of Science ®Google Scholar
• Lei M, Wang JG, Xiao DM, Fan M, Wang DP, Xiong JY, Chen Y, Ding Y, Liu SL. 2012. Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity. Eur J Pharmacol. 674:73–79.
   PubMed Web of Science ®Google Scholar
• Liu X, Teichtahl AJ, Wicks IP. 2015. Interleukin-6 in rheumatoid arthritis – from the laboratory to the bedside. Curr Pharm Des. 21:2187–2197.
   PubMed Web of Science ®Google Scholar
• Lopalco G, Cantarini L, Vitale A, Iannone F, Anelli MG, Andreozzi L, Lapadula G, Galeazzi M, Rigante D. 2015. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm. 2015:Article ID 194864.
   Web of Science ®Google Scholar
• Lubberts E. 2015. Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment. Curr Pharm Des. 21:142–146.
   PubMed Web of Science ®Google Scholar
• Mamehara A, Sugimoto T, Sugiyama D, Morinobu S, Tsuji G, Kawano S, Morinobu A, Kumagai S. 2010. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs. Kobe J Med Sci. 56:E98–E107.
   PubMedGoogle Scholar
• Manktelow A, Meyer AA. 1986. Lack of correlation between decreased chemotaxis and susceptibility to infection in burned rats. J Trauma. 26:143–148.
   PubMedGoogle Scholar
• Márk L, Márki-Zay J, Orosz I, Kondacs A, Erdei F, Katona A. 2003. [Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease]. Orv Hetil. 144:765–768.
   PubMedGoogle Scholar
• Maruyama S, Kato K, Kodama M, Hirono S, Fuse K, Nakagawa O, Nakazawa M, Miida T, Yamamoto T, Watanabe K, et al. 2002. Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats. J Atheroscler Thromb. 9:87–92.
   PubMedGoogle Scholar
• McInnes IB, Schett G. 2011. The pathogenesis of rheumatoid arthritis. N Engl J Med. 365:2205–2219.
   PubMed Web of Science ®Google Scholar
• Medeiros MM, Oliveira BM, Cerqueira JV, Quixadá RT, Oliveira ÍM. 2015. Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population. Rev Bras Reumatol. 55:477–484.
   PubMed Web of Science ®Google Scholar
• Mobasheri A, Shakibaei M. 2013. Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis. Ann N Y Acad Sci. 1290:59–66.
   PubMed Web of Science ®Google Scholar
• Moran E, Ding L, Wang Z, Cheng R, Chen Q, Moore R, Takahashi Y, Ma JX. 2014. Protective and antioxidant effects of PPARα in the ischemic retina. Invest Ophthalmol Vis Sci. 55:4568–4576.
   PubMed Web of Science ®Google Scholar
• Nagase H. 1998. Matrix metalloproteinases. In: Barrett AJ, Rawlings ND, Woessner JF, editors. Handbook of proteolytic enzymes. San Diego (CA): Academic Press. p. 1172–1178.
   Google Scholar
• Newbound BB. 1963. Chemotherapy of arthritis induced in rats by mycobacterial adjuvants. Br J Pharmacol Chemother. 21:127–136.
   PubMed Web of Science ®Google Scholar
• Ngo ST, Steyn FJ, McCombe PA. 2014. Gender differences in autoimmune disease. Front Neuroendocrinol. 35:347–369.
   PubMed Web of Science ®Google Scholar
• Nicoletti NF, Rodrigues-Junior V, Santos AA Jr, Leite CE, Dias AC, Batista EL Jr, Basso LA, Campos MM, Santos DS, Souto AA. 2014. Protective effects of resveratrol on hepatotoxicity induced by isoniazid and rifampicin via SIRT1 modulation. J Nat Prod. 77:2190–2195.
   PubMed Web of Science ®Google Scholar
• Osada M, Sakai T, Kuroyanagi K, Kohno H, Tsuneoka H. 2014. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate. Mol Vis. 20:1518–1526.
   PubMed Web of Science ®Google Scholar
• Pangeni R, Sharma S, Mustafa G, Ali J, Baboota S. 2014. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress. Nanotechnology 25:Article ID 485102.
   PubMed Web of Science ®Google Scholar
• Patel SS, Shah PV. 2013. Evaluation of anti-inflammatory potential of the multidrug herbomineral formulation in male Wistar rats against rheumatoid arthritis. J Ayurveda Integr Med. 4:86–93.
   PubMedGoogle Scholar
• Paulsson M, Heinegård D. 1981. Purification and structural characterization of a cartilage matrix protein. Biochem J. 197:367–375.
   PubMed Web of Science ®Google Scholar
• Petersen SG, Saxne T, Heinegard D, Hansen M, Holm L, Koskinen S, Stordal C, Christensen H, Aagaard P, Kjaer M. 2010. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training. Osteoarthritis Cartilage. 18:34–40.
   PubMed Web of Science ®Google Scholar
• Rau R. 2014. Glucocorticoid treatment in rheumatoid arthritis. Expert Opin Pharmacother. 15:1575–1583.
   PubMed Web of Science ®Google Scholar
• Saxena A, Khosraviani S, Noel S, Mohan D, Donner T, Hamad AR. 2014. Interleukin-10 paradox: a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine 74:27–34.
   PubMed Web of Science ®Google Scholar
• Schultz DR, Arnold PI. 1990. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum. 20:129–147.
   PubMed Web of Science ®Google Scholar
• Sharma S, Gupta R, Thakur SC. 2014. Attenuation of collagen induced arthritis by Centella asiatica methanol fraction via modulation of cytokines and oxidative stress. Biomed Environ Sci. 27:926–938.
   PubMed Web of Science ®Google Scholar
• Singh S, Kumar R, Jain H, Gupta YK. 2015. Anti-inflammatory and antiarthritic activity of UNIM-301 (a polyherbal unani formulation) in Wistar rats. Pharmacognosy Res. 7:188–192.
   PubMedGoogle Scholar
• Snekhalatha U, Anburajan M, Venkatraman B, Menaka M. 2013. Evaluation of complete Freund’s adjuvant-induced arthritis in a Wistar rat model. Comparison of thermography and histopathology. Z Rheumatol. 72:375–382.
   PubMed Web of Science ®Google Scholar
• Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, Winyard PG, Kettle AJ. 2012. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology (Oxford). 51:1796–1803.
   PubMed Web of Science ®Google Scholar
• Su JF, Guo CJ, Wei JY, Yang JJ, Jiang YG, Li YF. 2003. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed Environ Sci. 16:1–8.
   PubMed Web of Science ®Google Scholar
• Suwalsky M, Villena F, Gallardo MJ. 2015. In vitro protective effects of resveratrol against oxidative damage in human erythrocytes. Biochim Biophys Acta. 1848:76–82.
   PubMed Web of Science ®Google Scholar
• Tian J, Chen JW, Gao JS, Li L, Xie X. 2013. Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Rheumatol Int. 33:1829–1835.
   PubMed Web of Science ®Google Scholar
• Valesini G, Gerardi MC, Iannuccelli C, Pacucci VA, Pendolino M, Shoenfeld Y. 2015. Citrullination and autoimmunity. Autoimmun Rev. 14:490–497.
   PubMed Web of Science ®Google Scholar
• Vivar N, Van Vollenhoven RF. 2014. Advances in the treatment of rheumatoid arthritis. Hand Clin. 6:31–39.
   Google Scholar
• von Mühlen CA, Tan EM. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 24:323–358.
   PubMed Web of Science ®Google Scholar
• Waaler E. 2007. On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. APMIS 115:422–438.
   PubMed Web of Science ®Google Scholar
• Wei W, Clockaerts S, Bastiaansen-Jenniskens YM, Gierman LM, Botter SM, Bierma-Zeinstra SM, Weinans H, Verhaar JA, Kloppenburg M, Zuurmond AM, et al. 2014. Statins and fibrates do not affect development of spontaneous cartilage damage in STR/Ort mice. Osteoarthritis Cartilage. 22:293–301.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu X, Chan CO, Mok DK, Chan SW, Yu Z, Chen S. 2014. Petroleum ether extractive of the hips of Rosa multiflora ameliorates collagen-induced arthritis in rats. J Ethnopharmacol. 157:45–54.
   PubMed Web of Science ®Google Scholar
• Yang FJ, He YH, Zhou JH. 2015. Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury. J Huazhong Univ Sci Technol Med Sci. 35:58–63.
   PubMed Web of Science ®Google Scholar
• Yu Y, Li S, Liu Y, Tian G, Yuan Q, Bai F, Wang W, Zhang Z, Ren G, Zhang Y, et al. 2015. Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway. Int Immunopharmacol. 25:74–82.
   PubMed Web of Science ®Google Scholar
• Yuan J, Lu L, Zhang Z, Zhang S. 2012. Dietary intake of resveratrol enhances the adaptive immunity of aged rats. Rejuvenation Res. 15:507–515.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang J, Zhang M, Nie L. 2014. Protective effect of Asarum extract in rats with adjuvant arthritis. Exp Ther Med. 8:1638–1642.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Sun W, Liang Y, Gao Y, Kong W, Guan Y, Feng J, Wang X. 2012. Fenofibrate inhibited the differentiation of T helper 17 cells in vitro. PPAR Res. 2012:Article ID 145654.
   Google Scholar
• Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H, Qiu J. 2011. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS One 6:e27081.
   PubMed Web of Science ®Google Scholar
• Zou T, Yang Y, Xia F, Huang A, Gao X, Fang D, Xiong S, Zhang J. 2013. Resveratrol inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1. PLoS One 8:e75139.
   PubMed Web of Science ®Google Scholar